255 related articles for article (PubMed ID: 25379017)
21. Prostate-derived Ets factor, an oncogenic driver in breast cancer.
Sood AK; Geradts J; Young J
Tumour Biol; 2017 May; 39(5):1010428317691688. PubMed ID: 28468594
[TBL] [Abstract][Full Text] [Related]
22. Autocrine PDGFR signaling promotes mammary cancer metastasis.
Jechlinger M; Sommer A; Moriggl R; Seither P; Kraut N; Capodiecci P; Donovan M; Cordon-Cardo C; Beug H; Grünert S
J Clin Invest; 2006 Jun; 116(6):1561-70. PubMed ID: 16741576
[TBL] [Abstract][Full Text] [Related]
23. Synergistic Role of Endothelial ERG and FLI1 in Mediating Pulmonary Vascular Homeostasis.
Looney AP; Han R; Stawski L; Marden G; Iwamoto M; Trojanowska M
Am J Respir Cell Mol Biol; 2017 Jul; 57(1):121-131. PubMed ID: 28248553
[TBL] [Abstract][Full Text] [Related]
24. Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines.
Gilles C; Polette M; Birembaut P; Brünner N; Thompson EW
Clin Exp Metastasis; 1997 Sep; 15(5):519-26. PubMed ID: 9247254
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.
Turner DP; Findlay VJ; Moussa O; Semenchenko VI; Watson PM; LaRue AC; Desouki MM; Fraig M; Watson DK
Prostate; 2011 Dec; 71(16):1723-35. PubMed ID: 21446014
[TBL] [Abstract][Full Text] [Related]
26. Profile of Ets gene expression in human breast carcinoma.
He J; Pan Y; Hu J; Albarracin C; Wu Y; Dai JL
Cancer Biol Ther; 2007 Jan; 6(1):76-82. PubMed ID: 17172821
[TBL] [Abstract][Full Text] [Related]
27. Fli-1 overexpression in erythroleukemic cells promotes erythroid de-differentiation while Spi-1/PU.1 exerts the opposite effect.
Vecchiarelli-Federico LM; Liu T; Yao Y; Gao Y; Li Y; Li YJ; Ben-David Y
Int J Oncol; 2017 Aug; 51(2):456-466. PubMed ID: 28586009
[TBL] [Abstract][Full Text] [Related]
28. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
[TBL] [Abstract][Full Text] [Related]
29. Suppressive effects of a proton beam on tumor growth and lung metastasis through the inhibition of metastatic gene expression in 4T1 orthotopic breast cancer model.
Kwon YS; Lee KS; Chun SY; Jang TJ; Nam KS
Int J Oncol; 2016 Jul; 49(1):336-42. PubMed ID: 27176787
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
[TBL] [Abstract][Full Text] [Related]
31. Modulation of tumor fatty acids, through overexpression or loss of thyroid hormone responsive protein spot 14 is associated with altered growth and metastasis.
Wellberg EA; Rudolph MC; Lewis AS; Padilla-Just N; Jedlicka P; Anderson SM
Breast Cancer Res; 2014 Dec; 16(6):481. PubMed ID: 25472762
[TBL] [Abstract][Full Text] [Related]
32. Oncofetal H19 RNA promotes tumor metastasis.
Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
[TBL] [Abstract][Full Text] [Related]
33. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
34. TGF-β1 induces HMGA1 expression in human breast cancer cells: implications of the involvement of HMGA1 in TGF-β signaling.
Zu X; Zhong J; Tan J; Tan L; Yang D; Zhang Q; Ding W; Liu W; Wen G; Liu J; Cao R; Jiang Y
Int J Mol Med; 2015 Mar; 35(3):693-701. PubMed ID: 25572132
[TBL] [Abstract][Full Text] [Related]
35. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
36. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor.
Steffan JJ; Koul HK
Cancer Lett; 2011 Nov; 310(1):109-17. PubMed ID: 21764212
[TBL] [Abstract][Full Text] [Related]
37. Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex.
Cho JY; Lee M; Ahn JM; Park ES; Cho JH; Lee SJ; Kim BG; Heo SH; Park HJ; Zerbini LF; Hwang D; Libermann TA
J Proteome Res; 2009 Mar; 8(3):1327-37. PubMed ID: 19203193
[TBL] [Abstract][Full Text] [Related]
38. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.
Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Buggy Y; Young LS
Clin Cancer Res; 2005 Mar; 11(6):2111-22. PubMed ID: 15788656
[TBL] [Abstract][Full Text] [Related]
39. Sam-pointed domain containing Ets transcription factor in luminal breast cancer pathogenesis.
Sood AK; Wang J; Mhawech-Fauceglia P; Jana B; Liang P; Geradts J
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1899-903. PubMed ID: 19505923
[TBL] [Abstract][Full Text] [Related]
40. Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo.
Ghadersohi A; Pan D; Fayazi Z; Hicks DG; Winston JS; Li F
Breast Cancer Res Treat; 2007 Mar; 102(1):19-30. PubMed ID: 16897429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
